LYEL (Lyell Immunopharma, Inc.) Stock Market Reviews

crown

search

Read and share opinions on LYEL (Lyell Immunopharma, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

LYEL

Lyell Immunopharma, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Lyell Immunopharma: Q3 Earnings Snapshot
Nov 12, 2025
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
Nov 10, 2025
Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition
Nov 3, 2025
Lyell Immunopharma Announces the Initiation of a Phase 3 Head-to-Head CAR T-Cell Therapy Clinical Trial in Aggressive Large B-Cell Lymphoma and Formation of Expert Steering Committee
Sep 3, 2025
Lyell Immunopharma Announces Participation in September Investor Conferences
Sep 2, 2025
Lyell Immunopharma: Q2 Earnings Snapshot
Aug 12, 2025
Update: Lyell Immunopharma Shares Rise on Plan to Raise Up to $100 Million in Private Placement
Jul 25, 2025
Lyell Immunopharma to Raise $100 Million in Private Placement; Shares Rise Pre-Bell
Jul 25, 2025
Lyell Immunopharma Announces up to $100 Million Equity Private Placement
Jul 25, 2025
Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series
Jun 23, 2025
Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments
Jun 9, 2025
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
Jun 4, 2025
Lyell Immunopharma: Q1 Earnings Snapshot
May 13, 2025

Reviews